Prevention, Diagnosis, and Treatment of Cervical Cancer

Harry J. Long, Nadia N Laack, Bobbie S. Gostout

Research output: Contribution to journalArticle

Abstract

This article reviews the current data on human papillomavirus as the cause of most cervical cancer cases, data on the recently approved human papillomavirus vaccines, and updated information concerning the Bethesda System for interpretation of Papanicolaou test results. Current recommendations for surgical treatment, concurrent chemotherapy, and radiation therapy and recent advances in systemic therapy for advanced or metastatic cervical cancer are reviewed.

Original languageEnglish (US)
Pages (from-to)1566-1574
Number of pages9
JournalMayo Clinic Proceedings
Volume82
Issue number12
DOIs
StatePublished - Dec 1 2007

Fingerprint

Uterine Cervical Neoplasms
Papanicolaou Test
Papillomavirus Vaccines
Radiotherapy
Drug Therapy
Therapeutics

Keywords

  • cervical intraepithelial neoplasia
  • CIN
  • FIGO
  • Fédération Internationale de Gynécologie et d'Obstétrique
  • GOG
  • Gynecologic Oncology Group
  • hazard ratio
  • HDR
  • high-dose rate
  • HPV
  • HR
  • human papillomavirus
  • LDR
  • low-dose rate
  • Pap
  • Papanicolaou

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Prevention, Diagnosis, and Treatment of Cervical Cancer. / Long, Harry J.; Laack, Nadia N; Gostout, Bobbie S.

In: Mayo Clinic Proceedings, Vol. 82, No. 12, 01.12.2007, p. 1566-1574.

Research output: Contribution to journalArticle

Long, Harry J. ; Laack, Nadia N ; Gostout, Bobbie S. / Prevention, Diagnosis, and Treatment of Cervical Cancer. In: Mayo Clinic Proceedings. 2007 ; Vol. 82, No. 12. pp. 1566-1574.
@article{94956be74cf44975a3720384b5310bb8,
title = "Prevention, Diagnosis, and Treatment of Cervical Cancer",
abstract = "This article reviews the current data on human papillomavirus as the cause of most cervical cancer cases, data on the recently approved human papillomavirus vaccines, and updated information concerning the Bethesda System for interpretation of Papanicolaou test results. Current recommendations for surgical treatment, concurrent chemotherapy, and radiation therapy and recent advances in systemic therapy for advanced or metastatic cervical cancer are reviewed.",
keywords = "cervical intraepithelial neoplasia, CIN, FIGO, F{\'e}d{\'e}ration Internationale de Gyn{\'e}cologie et d'Obst{\'e}trique, GOG, Gynecologic Oncology Group, hazard ratio, HDR, high-dose rate, HPV, HR, human papillomavirus, LDR, low-dose rate, Pap, Papanicolaou",
author = "Long, {Harry J.} and Laack, {Nadia N} and Gostout, {Bobbie S.}",
year = "2007",
month = "12",
day = "1",
doi = "10.1016/S0025-6196(11)61104-X",
language = "English (US)",
volume = "82",
pages = "1566--1574",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "12",

}

TY - JOUR

T1 - Prevention, Diagnosis, and Treatment of Cervical Cancer

AU - Long, Harry J.

AU - Laack, Nadia N

AU - Gostout, Bobbie S.

PY - 2007/12/1

Y1 - 2007/12/1

N2 - This article reviews the current data on human papillomavirus as the cause of most cervical cancer cases, data on the recently approved human papillomavirus vaccines, and updated information concerning the Bethesda System for interpretation of Papanicolaou test results. Current recommendations for surgical treatment, concurrent chemotherapy, and radiation therapy and recent advances in systemic therapy for advanced or metastatic cervical cancer are reviewed.

AB - This article reviews the current data on human papillomavirus as the cause of most cervical cancer cases, data on the recently approved human papillomavirus vaccines, and updated information concerning the Bethesda System for interpretation of Papanicolaou test results. Current recommendations for surgical treatment, concurrent chemotherapy, and radiation therapy and recent advances in systemic therapy for advanced or metastatic cervical cancer are reviewed.

KW - cervical intraepithelial neoplasia

KW - CIN

KW - FIGO

KW - Fédération Internationale de Gynécologie et d'Obstétrique

KW - GOG

KW - Gynecologic Oncology Group

KW - hazard ratio

KW - HDR

KW - high-dose rate

KW - HPV

KW - HR

KW - human papillomavirus

KW - LDR

KW - low-dose rate

KW - Pap

KW - Papanicolaou

UR - http://www.scopus.com/inward/record.url?scp=85028842110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028842110&partnerID=8YFLogxK

U2 - 10.1016/S0025-6196(11)61104-X

DO - 10.1016/S0025-6196(11)61104-X

M3 - Article

AN - SCOPUS:85028842110

VL - 82

SP - 1566

EP - 1574

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 12

ER -